For a hedged play on Acorda Therapeutics (ACOR), MarketIntelligenceCenter.com’s option-trade picking algorithms recommend the Oct 19, 2018 $23 covered call for a net debit in the $19.94 area. That is also the break-even stock price …
Acorda Therapeutics, Inc. ACOR reported adjusted earnings of 61 cents per share ... Acorda’s shares decreased almost 2% following its earnings release. In fact the stock has dipped 0.8% in a year’s time, comparing favorably with the …
The boss of one of the world's biggest hotel chains is a 'glass half full' sort of guy. Richard tries to find out what worries Accor's CEO. Listen to his response... 05:49 Exclusive: VTB Chairman speaks out after being hit by U.S. sanctions
SmarTrend identified an Uptrend for Acorda Therapeut (NASDAQ:ACOR) on December 27th, 2017 at $22.40. In approximately 2 months, Acorda Therapeut has returned 11.38% as of today's recent price of $24.95. In the past 52 …
Its lead drug candidate, CVT-301, shows strong potential. The company stock is priced attractively after a sudden slump in its value. Acorda Therapeutics Inc. (NASDAQ:ACOR) stock shows a strong recovery from its April slump, which erased …
It has been about a month since the last earnings report for Acorda Therapeutics, Inc. ACOR. Shares have lost about 8.4% in that time frame, underperforming the market. Will the recent negative trend continue leading up to the stock's …
Yahoo!10mon